Attached files

file filename
10-K - FORM 10-K - PDL BIOPHARMA, INC.d10k.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - PDL BIOPHARMA, INC.dex211.htm
EX-31.2 - CERTIFICATION OF PFO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) - PDL BIOPHARMA, INC.dex312.htm
EX-31.1 - CERTIFICATION OF PEO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) - PDL BIOPHARMA, INC.dex311.htm
EX-10.29 - OFFER LETTER BETWEEN THE COMPANY AND CHRISTOPHER STONE - PDL BIOPHARMA, INC.dex1029.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - PDL BIOPHARMA, INC.dex231.htm

Exhibit 32.1

CERTIFICATION

John P. McLaughlin, President and Chief Executive Officer, and Christine R. Larson, Vice President and Chief Financial Officer, of PDL BioPharma, Inc. (the “Registrant”), each hereby certifies in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based on his or her knowledge:

(1) The Annual Report on Form 10-K for the fiscal year ended December 31, 2009 of the Registrant, to which this certification is attached as an exhibit (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

A signed original of this written statement required by Section 906 will be provided to the Securities and Exchange Commission or its staff upon request.

Dated: March 1, 2010

 

  By:
 

/s/    JOHN P. MCLAUGHLIN        

John P. McLaughlin

President and Chief Executive Officer

(Principal Executive Officer)

 

/s/    CHRISTINE R. LARSON        

Christine R. Larson

Vice President and Chief Financial Officer

(Principal Financial Officer)